Donor activating KIR2DS1 in leukemia

New England Journal of Medicine

Volumn 371, Issue 21, 2014, Pages 2042-

  Venstrom, Jeffrey M ^a   Dupont, Bo ^b   Hsu, Katharine C ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA C ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR;

ALLELE; ANALYTICAL ERROR; COHORT ANALYSIS; GENE AMPLIFICATION; GENE FREQUENCY; GENOTYPE; HUMAN; KIR2DS1 GENE; LETTER; LEUKEMIA; LEUKEMIA RELAPSE; POLYMERASE CHAIN REACTION; GENETICS; LEUKEMIA, MYELOID, ACUTE;

HLA-C ANTIGENS; HUMANS; LEUKEMIA, MYELOID, ACUTE; RECEPTORS, KIR;

EID: 84911423062     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1411443     Document Type: Letter

References (2)

1. Venstrom JM, Pittari G, Gooley TA, et al. HLA-C - dependent prevention of leukemia relapse by donor activating KIR2DS1. N Engl J Med 2012;367:805-16.
2. Hsu KC, Liu XR, Selvakumar A, Mickelson E, O'Reilly RJ, Dupont B. Killer Ig-like receptor haplotype analysis by gene content: evidence for genomic diversity with a minimum of six basic framework haplotypes, each with multiple subsets. J Immunol 2002;169:5118-29.